Becton, Dickinson and Company
Revenue Breakdown
| Fiscal Year | BD Medical | BD Life Sciences | BD Interventional | Corporate and Other |
|---|---|---|---|---|
| FY2022 | $8.84B | $5.56B | $4.46B | — |
| FY2023 | $9.50B | $5.13B | $4.74B | — |
| FY2024 | $10.07B | $5.19B | $4.98B | $-67.0M |
Revenue Breakdown
| Fiscal Year | BD Medical | BD Life Sciences | BD Interventional | Corporate and Other |
|---|---|---|---|---|
| FY2022 | $8.84B | $5.56B | $4.46B | — |
| FY2023 | $9.50B | $5.13B | $4.74B | — |
| FY2024 | $10.07B | $5.19B | $4.98B | $-67.0M |